My Quote Request
No products added yet
6505-01-524-8837
20 Products
NDC63323-0186-20
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015248837
NSN
6505-01-524-8837
NDC63323-0186-20
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505015248837
NSN
6505-01-524-8837
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 401200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION VIAL 20ML 25S
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SODIUM CHLORIDE 9%; PLASTIC VIAL; 20 ML SIZE; 9MG/ML (CONCENTRATION); STORE AT CONTROLLED ROOM TEMPERATURE; DO NOT PERMIT TO FREEZE; PRESERVATIVE FREE; 25/PKG
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
04-1428
NIACIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505015249144
NSN
6505-01-524-9144
04-1428
NIACIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505015249144
NSN
6505-01-524-9144
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NIACIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 240692
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NIACIN EXTENDED RELEASE TABLETS 500 MG BT 100S
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED ACTION NIACIN TABLETS; ITEM IS USED AS AN ADJUNCT TO DIET FOR REDUCTION OF ELEVATED TC, LDL-C, APO B AND TG LEVELS, AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA WHEN THE RESPONSE TO AN APPROPRIATE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: DIET HAS BEEN INADEQUATE; STORE AT ROOM TEMPERATURE (20 TO 25 DEGREES C OR 68 TO 77 DEGREES F)
Related Searches:
NDC60598-0001-01
NIACIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505015249144
NSN
6505-01-524-9144
NDC60598-0001-01
NIACIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505015249144
NSN
6505-01-524-9144
MFG
KOS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS NIACIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 240692
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NIACIN EXTENDED RELEASE TABLETS 500 MG BT 100S
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED ACTION NIACIN TABLETS; ITEM IS USED AS AN ADJUNCT TO DIET FOR REDUCTION OF ELEVATED TC, LDL-C, APO B AND TG LEVELS, AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA WHEN THE RESPONSE TO AN APPROPRIATE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: DIET HAS BEEN INADEQUATE; STORE AT ROOM TEMPERATURE (20 TO 25 DEGREES C OR 68 TO 77 DEGREES F)
Related Searches:
04-1433
LORATADINE TABLETS
NSN, MFG P/N
6505015249179
NSN
6505-01-524-9179
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LORATADINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 040800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORATADINE TABELTS 10 MG (500) PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CLARITIN TEMPORARILY RELIEVES SYMPTONS DUE TO HAY FEVER OR OTHER UPPER RESPIRATORY ALLERGIES; STORE BETWEEN 2 AND 30 DEGREES C (36 DEGREES AND 86 DEGREES F); PROTECT FROM EXCESSIVE MOISTURE
Related Searches:
CLARITIN
LORATADINE TABLETS
NSN, MFG P/N
6505015249179
NSN
6505-01-524-9179
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LORATADINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 040800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORATADINE TABELTS 10 MG (500) PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CLARITIN TEMPORARILY RELIEVES SYMPTONS DUE TO HAY FEVER OR OTHER UPPER RESPIRATORY ALLERGIES; STORE BETWEEN 2 AND 30 DEGREES C (36 DEGREES AND 86 DEGREES F); PROTECT FROM EXCESSIVE MOISTURE
Related Searches:
NDC11523-7160-08
LORATADINE TABLETS
NSN, MFG P/N
6505015249179
NSN
6505-01-524-9179
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LORATADINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 040800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORATADINE TABELTS 10 MG (500) PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CLARITIN TEMPORARILY RELIEVES SYMPTONS DUE TO HAY FEVER OR OTHER UPPER RESPIRATORY ALLERGIES; STORE BETWEEN 2 AND 30 DEGREES C (36 DEGREES AND 86 DEGREES F); PROTECT FROM EXCESSIVE MOISTURE
Related Searches:
NDC51660-0526-05
LORATADINE TABLETS
NSN, MFG P/N
6505015249179
NSN
6505-01-524-9179
MFG
OHM LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS LORATADINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 040800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORATADINE TABELTS 10 MG (500) PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CLARITIN TEMPORARILY RELIEVES SYMPTONS DUE TO HAY FEVER OR OTHER UPPER RESPIRATORY ALLERGIES; STORE BETWEEN 2 AND 30 DEGREES C (36 DEGREES AND 86 DEGREES F); PROTECT FROM EXCESSIVE MOISTURE
Related Searches:
04-1427
LEVONORGESTREL TABLETS
NSN, MFG P/N
6505015249195
NSN
6505-01-524-9195
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.0750 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVONORGESTREL TABLETS 0.75 MG 2S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: LEVONORGESTREL TABLETS ARE IN BLISTER PACK; ITEM IS AN EMERGENCY CONTRACEPTIVE THAT CAN BE USED TO PREVENT PREGNANCY FOLLOWING UNPROTECTED INTERCOURSE OR A KNOWN OR SUSPECTED CONTRACEPTEIVE FAILURE; TO OBTAIN OPTIMAL EFFICACY; THE FIRST TABLET SHOULD BE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: TAKEN AS SOON AS POSSIBLE WITHIN 72 HOURS OF INTERCOURSE; THE SECOND TABLET MUST BE TAKEN 12 HOURS LATER
Related Searches:
NDC51285-0769-93
LEVONORGESTREL TABLETS
NSN, MFG P/N
6505015249195
NSN
6505-01-524-9195
NDC51285-0769-93
LEVONORGESTREL TABLETS
NSN, MFG P/N
6505015249195
NSN
6505-01-524-9195
MFG
DURAMED PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.0750 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVONORGESTREL TABLETS 0.75 MG 2S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: LEVONORGESTREL TABLETS ARE IN BLISTER PACK; ITEM IS AN EMERGENCY CONTRACEPTIVE THAT CAN BE USED TO PREVENT PREGNANCY FOLLOWING UNPROTECTED INTERCOURSE OR A KNOWN OR SUSPECTED CONTRACEPTEIVE FAILURE; TO OBTAIN OPTIMAL EFFICACY; THE FIRST TABLET SHOULD BE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: TAKEN AS SOON AS POSSIBLE WITHIN 72 HOURS OF INTERCOURSE; THE SECOND TABLET MUST BE TAKEN 12 HOURS LATER
Related Searches:
PLAN B 2S
LEVONORGESTREL TABLETS
NSN, MFG P/N
6505015249195
NSN
6505-01-524-9195
MFG
DURAMED PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.0750 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681200
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVONORGESTREL TABLETS 0.75 MG 2S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: LEVONORGESTREL TABLETS ARE IN BLISTER PACK; ITEM IS AN EMERGENCY CONTRACEPTIVE THAT CAN BE USED TO PREVENT PREGNANCY FOLLOWING UNPROTECTED INTERCOURSE OR A KNOWN OR SUSPECTED CONTRACEPTEIVE FAILURE; TO OBTAIN OPTIMAL EFFICACY; THE FIRST TABLET SHOULD BE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: TAKEN AS SOON AS POSSIBLE WITHIN 72 HOURS OF INTERCOURSE; THE SECOND TABLET MUST BE TAKEN 12 HOURS LATER
Related Searches:
04-1471
CEFOTAXIME FOR INJE
NSN, MFG P/N
6505015249732
NSN
6505-01-524-9732
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081206
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOTAXIME FOR INJECTION USP 1 GM EQUIVALENT 10 ML (25) SINGLE DOSE VIALS PER PACKAGE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1 GM CEFOTAXIME EQUIVALENT; ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS: PRIMARY CONTAINER TYPE: VIAL SINGLE DOSE; PRIMARY CONTAINER CONTENT QUANITY: 10 ML; TOTAL PRIMARY CONTAINER QUANITITY 25 FEATURE PROVIDED:
~1: STERILE; CEFOTAXIME IS INDICATED FOR THE TREATMENT OF PATIENTS WITH SERIOUS INFECTION CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICROOGRANISMS IN THE LOWER RESPIRATORY TRACT, GENITOURINARY INFECTIONS, GYNECOLOGIC INFECTIONS, BACTEREMIA/SEPTICEMIA,
~2: SKIN AND SKIN STRUCTURE INFECTIONS, INTRA-ABDOMINAL INFECTIONS, BONE AND JOINT INFECTIONS, AND CENTRAL NERVOUS SYSTEM INFECTIONS; STORE AT CONTROLLED ROOM TEMPERATURE
Related Searches:
NDC63323-0331-15
CEFOTAXIME FOR INJE
NSN, MFG P/N
6505015249732
NSN
6505-01-524-9732
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081206
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOTAXIME FOR INJECTION USP 1 GM EQUIVALENT 10 ML (25) SINGLE DOSE VIALS PER PACKAGE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1 GM CEFOTAXIME EQUIVALENT; ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS: PRIMARY CONTAINER TYPE: VIAL SINGLE DOSE; PRIMARY CONTAINER CONTENT QUANITY: 10 ML; TOTAL PRIMARY CONTAINER QUANITITY 25 FEATURE PROVIDED:
~1: STERILE; CEFOTAXIME IS INDICATED FOR THE TREATMENT OF PATIENTS WITH SERIOUS INFECTION CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICROOGRANISMS IN THE LOWER RESPIRATORY TRACT, GENITOURINARY INFECTIONS, GYNECOLOGIC INFECTIONS, BACTEREMIA/SEPTICEMIA,
~2: SKIN AND SKIN STRUCTURE INFECTIONS, INTRA-ABDOMINAL INFECTIONS, BONE AND JOINT INFECTIONS, AND CENTRAL NERVOUS SYSTEM INFECTIONS; STORE AT CONTROLLED ROOM TEMPERATURE
Related Searches:
04-1450
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505015250326
NSN
6505-01-525-0326
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE INJECTION 10MG/ML 10ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10MG FUROSEMIDE PER ML; 10ML VIALS
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00409-6102-10
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505015250326
NSN
6505-01-525-0326
NDC00409-6102-10
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505015250326
NSN
6505-01-525-0326
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE INJECTION 10MG/ML 10ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10MG FUROSEMIDE PER ML; 10ML VIALS
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
300-00650
LUBRICANT,SURGICAL
NSN, MFG P/N
6505015250875
NSN
6505-01-525-0875
MFG
MEDICAL PLASTICS LAB /MPL/
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT MANIKIN SPRAY
SPECIAL FEATURES: FOR USE WITH THE MULTI-VENOUS ACCESS ARM KIT
Related Searches:
04-1473
MULTIVITAMIN SOLUTION FOR INJECTION
NSN, MFG P/N
6505015253014
NSN
6505-01-525-3014
04-1473
MULTIVITAMIN SOLUTION FOR INJECTION
NSN, MFG P/N
6505015253014
NSN
6505-01-525-3014
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ADMINISTRATION: INTRAVENOUS INFUSION
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 882800
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MULTIVITAMIN SOLUTION F/INJ 10ML DUAL-CHAMBER VIAL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: MUTIVITAMIN SOLUTION FOR INJECTION; ADULT; DUAL-CHAMBER; SINGLE DOSE VIAL; MUST BE MIXED JUST PRIOR TO USE; PROVIDES ONE 10ML DOSE; FOR INTRAVENOUS INFUSIONS ONLY; STORE AT 2 TO 8DEG. C; BOX/10
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC61703-0422-81
MULTIVITAMIN SOLUTION FOR INJECTION
NSN, MFG P/N
6505015253014
NSN
6505-01-525-3014
NDC61703-0422-81
MULTIVITAMIN SOLUTION FOR INJECTION
NSN, MFG P/N
6505015253014
NSN
6505-01-525-3014
MFG
MAYNE PHARMA USA INC
Description
ADMINISTRATION: INTRAVENOUS INFUSION
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 882800
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MULTIVITAMIN SOLUTION F/INJ 10ML DUAL-CHAMBER VIAL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: MUTIVITAMIN SOLUTION FOR INJECTION; ADULT; DUAL-CHAMBER; SINGLE DOSE VIAL; MUST BE MIXED JUST PRIOR TO USE; PROVIDES ONE 10ML DOSE; FOR INTRAVENOUS INFUSIONS ONLY; STORE AT 2 TO 8DEG. C; BOX/10
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
04-1326
ACETYLCHOLINE CHLORIDE FOR OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505015254068
NSN
6505-01-525-4068
04-1326
ACETYLCHOLINE CHLORIDE FOR OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505015254068
NSN
6505-01-525-4068
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS ACETYLCHOLINE CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INSTILLATION AND INTRAOCULAR
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 522000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCHOLINE CHLORIDE INTRAOCULAR SOLUTION 1% 2ML KIT
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT
SPECIAL FEATURES: AFTER RECONSTITUTION THIS WILL BE 2ML OF A 1% SOLUTION; MIOCHOL-E SYSTEM PAK CONTAINS THE FOLLOWING: 1 MIOCHOL-E 2ML STERILE UNIVIAL, 1 PACK NOVARTIS STERI-TAGS STERILE LABELS, 1 B-D 3ML STERILE SYRINGE AND 1 DYNAGARD 0.2 MICRON STERILE FILTER; STORE AT 4
~1: TO 25 DEG C; KEEP FROM FREEZING
Related Searches:
MIOCHOL-E SYSTEM PACK
ACETYLCHOLINE CHLORIDE FOR OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505015254068
NSN
6505-01-525-4068
MIOCHOL-E SYSTEM PACK
ACETYLCHOLINE CHLORIDE FOR OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505015254068
NSN
6505-01-525-4068
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS ACETYLCHOLINE CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INSTILLATION AND INTRAOCULAR
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 522000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCHOLINE CHLORIDE INTRAOCULAR SOLUTION 1% 2ML KIT
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT
SPECIAL FEATURES: AFTER RECONSTITUTION THIS WILL BE 2ML OF A 1% SOLUTION; MIOCHOL-E SYSTEM PAK CONTAINS THE FOLLOWING: 1 MIOCHOL-E 2ML STERILE UNIVIAL, 1 PACK NOVARTIS STERI-TAGS STERILE LABELS, 1 B-D 3ML STERILE SYRINGE AND 1 DYNAGARD 0.2 MICRON STERILE FILTER; STORE AT 4
~1: TO 25 DEG C; KEEP FROM FREEZING
Related Searches:
NDC00078-0474-61
ACETYLCHOLINE CHLORIDE FOR OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505015254068
NSN
6505-01-525-4068
NDC00078-0474-61
ACETYLCHOLINE CHLORIDE FOR OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505015254068
NSN
6505-01-525-4068
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS ACETYLCHOLINE CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INSTILLATION AND INTRAOCULAR
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 522000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCHOLINE CHLORIDE INTRAOCULAR SOLUTION 1% 2ML KIT
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT
SPECIAL FEATURES: AFTER RECONSTITUTION THIS WILL BE 2ML OF A 1% SOLUTION; MIOCHOL-E SYSTEM PAK CONTAINS THE FOLLOWING: 1 MIOCHOL-E 2ML STERILE UNIVIAL, 1 PACK NOVARTIS STERI-TAGS STERILE LABELS, 1 B-D 3ML STERILE SYRINGE AND 1 DYNAGARD 0.2 MICRON STERILE FILTER; STORE AT 4
~1: TO 25 DEG C; KEEP FROM FREEZING
